1939 Harrison St., Suite 929, Oakland, California 94612

Allergan’s IS a Botox Smile; or, No Mirth for Merz

Allergan, the maker of the first botulinium toxin cosmetic product (better known as Botox) is smiling today because it won a trade secret misappropriation trial against competitor Merz Pharmaceutical. Merz markets Xeomin,  another botulinium toxin product that until recently was authorized only for muscle cramps.
Allergan sued for trade secret misappropriation after Merz poached Allergan’s botox sales teams. Federal Judge Andrew Guilford of the Central District of California found the sales teams helped themselves to large doses of confidential sales information before blowing off Allergan. For all the advanced chemistry and biology involved, apparently the trade secrets misappropriated were garden variety (albeit vital) sales and customer information.
Judge Guilford’s full ruling and terms of the injunction are due on Friday, March 9th; we will provide a link here when it becomes available.
A hearty huzzah, though, for Merz’ counsel, Rick McKnight, who tried to make the best of a bad result: he is quoted as saying that he thinks the judge’s ruling after trial is a way of “encouraging settlement.”

Leave a Reply

Your email address will not be published. Required fields are marked *

    Just thought i’d drop in to say i love your style of writing, flows really well and easy to read. Thanks for posting this

    heya, good page, and a great understand! 1 for my bookmarks.

    Its good as your other posts , thanks for posting . – There is no sadder sight than a young pessimist. Mark Twain 1835 1910

    I was examining some of your content on this website and I believe this site is real instructive! Continue posting .


Contact Form

We will respond to your inquiry in a timely fashion. Thank you.

Quick Contact Form